Strain Profile · NCBI Strain Taxon 1408186
Save

Lactobacillus johnsonii N6.2

◐ Food-origin
Sequenced
Public genome assembly available

Lactobacillus johnsonii N6.2 has a moderately developed clinical evidence base, anchored by multiple double-blind, randomized human trials evaluating safety, tolerability, and host immune responses in healthy adults. These trials have examined immune function and specific immune cell populations. In vitro research has examined the strain's extracellular vesicles, including activity in relation to murine norovirus, immunomodulatory phospholipid interactions with dendritic cells, and pancreatic cell signaling; these remain preliminary and unconfirmed in human trials. Animal model work has explored gut flora-related autoimmunity research in an early-stage context. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 20 body-system-tagged papers that concern each system. Research coverage, not measured effect.

Symptoms in the research

Share of this strain's 5 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

Research

25 papers reference this strain in the probiotic database.

Match confidence
2025 IN_VITRO
Lactobacillus johnsonii N6.2 Phospholipids Induce T Cell Anergy upon Cognate Dendritic Cell Interactions
· Metabolites
2025 ANIMAL
Lactobacillus johnsonii N6.2 improves glycemia and reduces diabetes-induced organ injury in the db/db mice model
· Journal of Endocrinology
2024 IN_VITRO
The Sdp-SH3b2 domain contained in Lactobacillus johnsonii N6.2-derived extracellular vesicles inhibit murine norovirus replication
· Frontiers in Immunology
2023 IN_VITRO
Internalization of extracellular vesicles from Lactobacillus johnsonii N6.2 elicit an RNA sensory response in human pancreatic cell lines
· Journal of Extracellular Biology
2023 OBSERVATIONAL
Identification of food and nutrient components as predictors of Lactobacillus colonization
· Frontiers in Nutrition
2023 IN_VITRO
Lactobacillus johnsonii N6.2 phospholipids induce immature-like dendritic cells with a migratory-regulatory-like transcriptional signature
· Gut Microbes
2022 IN_VITRO
Nanovesicles From Lactobacillus johnsonii N6.2 Reduce Apoptosis in Human Beta Cells by Promoting AHR Translocation and IL10 Secretion
· Frontiers in Immunology
2021 IN_VITRO
Identification of Biomarkers for Systemic Distribution of Nanovesicles From Lactobacillus johnsonii N6.2
· Frontiers in Immunology
2020 IN_VITRO
Maturation of dendritic cells derived from type 1 diabetes-susceptible NOD mice is differentially regulated by two strains of generally regarded as safe (GRAS) Lactobacillus
· The Journal of Immunology
2019 IN_VITRO
Blueberries as an additive to increase the survival of Lactobacillus johnsonii N6.2 to lyophilisation
· Beneficial Microbes
2018 ANIMAL
Sex Modulates Lactobacillus johnsonii N6.2 and Phytophenol Effectiveness in Reducing High Fat Diet Induced mTOR Activation in Sprague-Dawley Rats
· Frontiers in Microbiology
2018 ANIMAL
Lactobacillus johnsonii N6.2 diminishes caspase-1 maturation in the gastrointestinal system of diabetes prone rats
· Beneficial Microbes
2017 RCT
Immunological effects of Lactobacillus johnsonii N6.2 in healthy adults: A double‐blind, randomized trial
· The FASEB Journal
2017 RCT
Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults
· Frontiers in Immunology
2016 RCT
A Double‐Blind, Randomized Human Trial To Evaluate The Safety, Tolerability, And Host Response To Lactobacillus johnsonii N6.2
· The FASEB Journal
2016 REVIEW
The Synergistic Contribution of Lactobacillus and Dietary Phytophenols in Host Health
· InTech eBooks
2015 ANIMAL
Gut bacteria modulation of antigen presenting cells in a mouse model of autoimmune diabetes. (THER5P.915)
· The Journal of Immunology
2015 IN_VITRO
H2O2 production rate in Lactobacillus johnsonii is modulated via the interplay of a heterodimeric flavin oxidoreductase with a soluble 28 Kd PAS domain containing protein
· Frontiers in Microbiology
2013 ANIMAL
Use of gut flora as a natural vaccine against autoimmunity
· Journal of Clinical & Cellular Immunology
2011 IN_VITRO
An Inserted α/β Subdomain Shapes the Catalytic Pocket of Lactobacillus johnsonii Cinnamoyl Esterase
· PLoS ONE
Browse all 25 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults
    · Frontiers in Immunology · 2017
    PMID 28659913 →
  2. [2]
    Immunological effects of Lactobacillus johnsonii N6.2 in healthy adults: A double‐blind, randomized trial
    · The FASEB Journal · 2017
    Source →
  3. [3]
    A Double‐Blind, Randomized Human Trial To Evaluate The Safety, Tolerability, And Host Response To Lactobacillus johnsonii N6.2
    · The FASEB Journal · 2016
    Source →